Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
consistent ~12-15% weight loss at 68 weeks Compound Tirzepatide (Zepbound) Class GIP/GLP-1 dual agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs
If you are low in B, an appropriate supplementation will be added
Last reviewed: May 12, 2026 Last updated: May 12, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Injection site reactions were mild and transient
US$ 22.85
US$ 21.19
US$ 27.64
US$ 27.68
US$ 22.42
US$ 23.65
US$ 27.71
US$ 25.58
